{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T11:02:16Z","timestamp":1692874936760},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,2,19]],"date-time":"2018-02-19T00:00:00Z","timestamp":1518998400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s00108-018-0382-9","type":"journal-article","created":{"date-parts":[[2018,2,19]],"date-time":"2018-02-19T10:31:54Z","timestamp":1519036314000},"page":"241-251","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Akuttherapie und Sekund\u00e4rprophylaxe des isch\u00e4mischen Schlaganfalls"],"prefix":"10.1007","volume":"59","author":[{"given":"R.","family":"Wachter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Gr\u00f6schel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,19]]},"reference":[{"key":"382_CR1","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1056\/NEJMoa0804656","volume":"359","author":"W Hacke","year":"2008","unstructured":"Hacke W, Kaste M, Bluhmki E et\u00a0al (2008) Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N\u00a0Engl J Med 359:1317\u20131329","journal-title":"N Engl J Med"},{"key":"382_CR2","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1055\/s-0042-101225","volume":"43","author":"P Ringleb","year":"2016","unstructured":"Ringleb P, Hamann GF, R\u00f6ther J et\u00a0al (2016) Akuttherapie des isch\u00e4mischen Schlaganfalls \u2013 Rekanalisierende Therapie. Aktuelle Neurol 43:82\u201391","journal-title":"Aktuelle Neurol."},{"key":"382_CR3","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1161\/STROKEAHA.110.592535","volume":"41","author":"R Bhatia","year":"2010","unstructured":"Bhatia R, Hill MD, Shobha N et al (2010) Low rates of acute recanalization with interavenous recombinant tissue plasminogen activator in ischemic stroke: real-world experience and a\u00a0call for action. Stroke 41:2254\u20132258","journal-title":"Stroke"},{"key":"382_CR4","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1001\/jama.282.21.2003","volume":"28","author":"A Furlan","year":"1999","unstructured":"Furlan A, Higashida R, Wechsler L et al (1999) Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a\u00a0randomized controlled trial. Prolyse in acute cerebral thromboembolism. JAMA 28:2003\u20132011","journal-title":"JAMA"},{"key":"382_CR5","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1161\/01.STR.0000171066.25248.1d","volume":"36","author":"WS Smith","year":"2005","unstructured":"Smith WS, Sung G, Starkman S et\u00a0al (2005) Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results oft he MERCI trial. Stroke 36:1432\u20131438","journal-title":"Stroke"},{"key":"382_CR6","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1056\/NEJMe1215730","volume":"368","author":"MI Chimowitz","year":"2013","unstructured":"Chimowitz MI (2013) Endovascular treatment for acute ischemic stroke \u2013 still unproven. N\u00a0Engl J Med 368:952\u2013955","journal-title":"N Engl J Med"},{"key":"382_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1411587","volume":"372","author":"OA Berkhemer","year":"2015","unstructured":"Berkhemer OA, Fransen PSS, Beumer D et\u00a0al (2015) A randomized trial of intraarterial treatment for acute ischemic stroke. N\u00a0Engl J Med 372:11\u201320","journal-title":"N Engl J Med"},{"key":"382_CR8","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/S0140-6736(16)00163-X","volume":"387","author":"M Goyal","year":"2016","unstructured":"Goyal M, Menon BH, van Zwam WH et al (2016) Endovascular thrombectomy after large-vessel ischaemic stroke: a\u00a0meta-analysis of individual patient dat afrom five randomised trials. Lancet 387:1723\u20131731","journal-title":"Lancet"},{"key":"382_CR9","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1161\/01.STR.20.7.864","volume":"20","author":"T Brott","year":"1989","unstructured":"Brott T, Adams HP, Olinger CP et\u00a0al (1989) Measurements of acute cerebral infarction a\u00a0clinical examination scale. Stroke 20:864\u2013870","journal-title":"Stroke"},{"key":"382_CR10","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1706442","author":"RG Nogueira","year":"2017","unstructured":"Nogueira RG, Jadhav AP, Haussen DC et\u00a0al (2017) Thrombectomy 6 to 24 hours after stroke with a\u00a0mismatch between deficit and infarct. N\u00a0Engl J Med. \n                    https:\/\/doi.org\/10.1056\/nejmoa1706442","journal-title":"N Engl J Med"},{"key":"382_CR11","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1136\/jnnp.2008.169102","volume":"80","author":"A Ter\u00e9nt","year":"2009","unstructured":"Ter\u00e9nt A, Asplund K, Farahmand B et al (2009) Stroke unit care revisited: who benefits the most? A cohort study of 105,043 patients in Riks-Stroke, the Swedish Stroke Register. J\u00a0Neurol Neurosurg Psychiatry 80:881\u2013887","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"382_CR12","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1056\/NEJMoa1311376","volume":"370","author":"DJ Gladstone","year":"2014","unstructured":"Gladstone DJ, Sharma M, Spence JD et\u00a0al (2014) Cryptogenic stroke and atrial fibrillation. N\u00a0Engl J Med 370:2467\u20132477","journal-title":"N Engl J Med"},{"key":"382_CR13","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1056\/NEJMoa1313600","volume":"370","author":"T Sanna","year":"2014","unstructured":"Sanna T, Diener H, Passman RS et\u00a0al (2014) Cryptogenic stroke and underlying atrial fibrillation. N\u00a0Engl J Med 370:2478\u20132486","journal-title":"N Engl J Med"},{"key":"382_CR14","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/S1474-4422(17)30002-9","volume":"16","author":"R Wachter","year":"2017","unstructured":"Wachter R, Gr\u00f6schel K, Gelbrich G et al (2017) Holter-electrocardiogram-monitoring in patients with acute ischaemic stroke (Find-AFRANDOMISED): an open-label randomised controlled trial. Lancet Neurol 16:282\u2013290","journal-title":"Lancet Neurol"},{"key":"382_CR15","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-118476","author":"KG H\u00e4usler","year":"2017","unstructured":"H\u00e4usler KG, Gr\u00f6schel K, K\u00f6hrmann M et\u00a0al (2017) Positionspapier zur Detektion von Vorhofflimmern nach isch\u00e4mischem Schlaganfall. Aktuelle Neurol. \n                    https:\/\/doi.org\/10.1055\/s-0043-118476","journal-title":"Aktuelle Neurol."},{"key":"382_CR16","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1161\/01.STR.0000072985.24967.7F","volume":"34","author":"T Hillen","year":"2003","unstructured":"Hillen T, Coshall C, Tilling K et\u00a0al (2003) Cause of stroke recurrence is multifactorial patterns, risk factors, and outcomes of stroke recurrence in the South London stroke register. Stroke 34:1457\u20131463","journal-title":"Stroke"},{"key":"382_CR17","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/S0140-6736(16)30468-8","volume":"388","author":"PM Rothwell","year":"2016","unstructured":"Rothwell PM, Algra A, Chen Z et al (2016) Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke: time-course analysis of randomised trials. Lancet 388:365\u2013375","journal-title":"Lancet"},{"key":"382_CR18","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1056\/NEJMoa1009639","volume":"366","author":"AJ Furlan","year":"2012","unstructured":"Furlan AJ, Reisman M, Massaro J et\u00a0al (2012) Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N\u00a0Engl J Med 366:991\u2013999","journal-title":"N Engl J Med"},{"key":"382_CR19","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1056\/NEJMoa1301440","volume":"368","author":"JD Carroll","year":"2013","unstructured":"Carroll JD, Saver JL, Thaler DE et\u00a0al (2013) Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N\u00a0Engl J Med 368:1092\u20131100","journal-title":"N Engl J Med"},{"key":"382_CR20","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1056\/NEJMoa1211716","volume":"368","author":"B Meier","year":"2013","unstructured":"Meier B, Kalesan B, Mattle HP et\u00a0al (2013) Percutaneous closure of patent foramen ovale in cryptogenic embolism. N\u00a0Engl J Med 368:1083\u20131091","journal-title":"N Engl J Med"},{"key":"382_CR21","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1056\/NEJMoa1610057","volume":"377","author":"JL Saver","year":"2017","unstructured":"Saver JL, Carroll JD, Thaler DE et al (2017) Long-term outcomes of patent foramen ovale closure or medical therapy after stroke. N\u00a0Engl J Med 377:1022\u20131032","journal-title":"N Engl J Med"},{"key":"382_CR22","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1056\/NEJMoa1707404","volume":"377","author":"L S\u00f8ndergaard","year":"2017","unstructured":"S\u00f8ndergaard L, Kasner SE, Rhodes JF et\u00a0al (2017) Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke. N\u00a0Engl J Med 377:1033\u20131042","journal-title":"N Engl J Med"},{"key":"382_CR23","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1056\/NEJMoa1705915","volume":"377","author":"JL Mas","year":"2017","unstructured":"Mas JL, Derumeaux G, Guillon B et\u00a0al (2017) Patent foramen ovale closure or anticoagulation versus antiplatelets after stroke. N\u00a0Engl J Med 377:1011\u20131021","journal-title":"N Engl J Med"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-018-0382-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-018-0382-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-018-0382-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T00:25:56Z","timestamp":1550535956000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-018-0382-9"}},"subtitle":["Ein Musterbeispiel f\u00fcr personalisierte Medizin"],"short-title":[],"issued":{"date-parts":[[2018,2,19]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["382"],"URL":"https:\/\/doi.org\/10.1007\/s00108-018-0382-9","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,19]]},"assertion":[{"value":"19 February 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"R.\u00a0Wachter erhielt von folgenden Firmen Honorare f\u00fcr Vortr\u00e4ge oder Mitarbeit in Advisory Boards: Bayer, Bristol-Myers Squibb, Boehringer Ingelheim, CVRx, Medtronic, Novartis, Pfizer, Sanofi und Servier. Seine Institution erhielt Forschungsunterst\u00fctzung von Boehringer Ingelheim, der Europ\u00e4ischen Union und dem Bundesministerium f\u00fcr Bildung und Forschung (BMBF). K.\u00a0Gr\u00f6schel erhielt von folgenden Firmen Honorare f\u00fcr Vortr\u00e4ge oder Mitarbeit in Advisory Boards: Bayer, Boehringer Ingelheim, Bristol-Meyers Squipp, Daiichi Sankyo und Pfizer.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}